Letters
The herbalists’ marketeer
Herbal drugs and public choice
BMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g4157 (Published 24 June 2014) Cite this as: BMJ 2014;348:g4157- Michael McIntyre, herbal practitioner/acupuncturist1,
- George Lewith, professor of health research2,
- Andrew Flower, National Institute for Health Research postdoctoral research fellow2,
- Sarah Price, research fellow2
- 1European Herbal and Traditional Medicine Practitioners Association, Tewkesbury GL20 5TY, UK
- 2Aldermoor Health Centre, University of Southampton, Southampton SO16 5ST, UK
- ehap{at}globalnet.co.uk
The Medicines and Healthcare Products Regulatory Agency (MHRA) and the Traditional Herbal Medicinal Products Directive (THMPD) do not promote herbal drugs or mislead consumers; they seek quality control and safety of herbal drugs.1 The THMPD does not guarantee efficacy; it describes traditional use. By granting traditional herbal registrations, the MHRA enables the provision of quality controlled herbal drugs that have a history of safe use.
Given the widespread use of herbal …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.